{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:53:34Z","timestamp":1792896814466,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jhep.2024.04.006","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T21:03:44Z","timestamp":1717794224000},"page":"303-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["EASL Clinical Practice Guidelines on genetic cholestatic liver diseases"],"prefix":"10.1016","volume":"81","author":[{"given":"Henkjan J.","family":"Verkade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Felzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Keitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"van Mil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2024.04.006_bib1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha(1)-Antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2024.04.006_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jhep.2021.11.022","article-title":"Alpha-1 antitrypsin deficiency: a re-surfacing adult liver disorder","volume":"76","author":"Fromme","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20159","article-title":"BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis","volume":"39","author":"Pauli-Magnus","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jhep.2024.04.006_bib5","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/s41467-018-04552-7","article-title":"Distinct epigenomic patterns are associated with haploinsufficiency and predict risk genes of developmental disorders","volume":"9","author":"Han","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2024.04.006_bib6","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/hep4.2051","article-title":"Clinical phenotype of adult-onset liver disease in patients with variants in ABCB4, ABCB11, and ATP8B1","volume":"6","author":"Nayagam","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2024.04.006_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00535-017-1423-1","article-title":"Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing","volume":"53","author":"Vitale","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2024.04.006_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104317","article-title":"The spectrum of Progressive Familial Intrahepatic Cholestasis diseases: update on pathophysiology and emerging treatments","volume":"64","author":"Felzen","year":"2021","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jhep.2024.04.006_bib150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clinre.2017.08.007","article-title":"An update on the physiopathology and therapeutic management of cholestatic pruritus in children","volume":"42","author":"Thebaut","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2024.04.006_bib151","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s12072-023-10578-x","article-title":"Management of adults with Alagille syndrome","volume":"17","author":"Ayoub","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2024.04.006_bib137","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.07.043","article-title":"Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy","volume":"137","author":"Gonzales","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.04.006_bib138","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/MPG.0b013e3181b97bd2","article-title":"Titration of bile acid supplements in 3beta-hydroxy-Delta 5-C27-steroid dehydrogenase\/isomerase deficiency","volume":"50","author":"Riello","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2024.04.006_bib142","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MPG.0000000000001657","article-title":"Oral cholic acid is efficacious and well tolerated in patients with bile acid synthesis and zellweger spectrum disorders","volume":"65","author":"Heubi","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2024.04.006_bib93","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0030-1253223","article-title":"The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects","volume":"30","author":"Davit-Spraul","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib112","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hep.510250303","article-title":"Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis","volume":"25","author":"Jacquemin","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib113","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1665-2681(19)30771-9","article-title":"Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3","volume":"14","author":"Frider","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib114","article-title":"Outcomes of 38 patients with PFIC3: impact of genotype and of response to ursodeoxycholic acid therapy","volume":"5","author":"Gonzales","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2024.04.006_bib118","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/hep.510290603","article-title":"Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. UDCA-PBC Study Group","volume":"29","author":"Poupon","year":"1999","journal-title":"Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.05.020","article-title":"Ursodeoxycholic acid therapy throughout pregnancy in women affected with chronic cholestasis of childhood: No evidence for teratogenicity","volume":"45","author":"Lykavieris","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2024.04.006_bib152","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53628-x","article-title":"Effect of food on the pharmacokinetics and therapeutic efficacy of 4-phenylbutyrate in progressive familial intrahepatic cholestasis","volume":"9","author":"Nakano","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2024.04.006_bib153","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jhep.2012.04.017","article-title":"Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2","volume":"57","author":"Gonzales","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib154","first-page":"141","article-title":"A drug regimen for progressive familial cholestasis type 2","author":"Malatack","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhep.2024.04.006_bib155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1750-1172-9-89","article-title":"Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1","volume":"9","author":"Hasegawa","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib156","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1111\/liv.14518","article-title":"Functional rescue of an ABCB11 mutant by ivacaftor: a new targeted pharmacotherapy approach in bile salt export pump deficiency","volume":"40","author":"Mareux","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2024.04.006_bib157","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/hep.26155","article-title":"Fibrates as adjuvant therapy for chronic cholestatic liver disease: its time has come","volume":"57","author":"Ghonem","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib46","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2024.04.006_bib47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2022.09.001","article-title":"Maralixibat treatment response in Alagille syndrome is associated with improved health-related quality of life","volume":"252","author":"Kamath","year":"2023","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2024.04.006_bib59","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MOG.0000000000000919","article-title":"Cleaning up alpha-1 antitrypsin deficiency related liver disease","volume":"39","author":"Rademacher","year":"2023","journal-title":"Curr Opin Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhep.2024.04.006_bib9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1055\/a-2122-7674","article-title":"Pediatric and adult liver disease in alpha1-antitrypsin deficiency","volume":"43","author":"Ruiz","year":"2023","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MPG.0000000000000753","article-title":"Baseline analysis of a young alpha-1-antitrypsin deficiency liver disease cohort reveals frequent portal hypertension","volume":"61","author":"Teckman","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2024.04.006_bib11","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/liv.14035","article-title":"Liver disease related to alpha1-antitrypsin deficiency in French children: the DEFI-ALPHA cohort","volume":"39","author":"Ruiz","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2024.04.006_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4939-7163-3_3","article-title":"Measuring and interpreting serum AAT concentration","volume":"1639","author":"Donato","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhep.2024.04.006_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00791-2016","article-title":"Management of COPD exacerbations: a European respiratory society\/American thoracic society guideline","volume":"49","author":"Wedzicha","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhep.2024.04.006_bib14","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2147\/COPD.S208591","article-title":"An analysis of the degree of concordance among international guidelines regarding alpha-1 antitrypsin deficiency","volume":"14","author":"Attaway","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/thoraxjnl-2011-201321","article-title":"Serum levels and genotype distribution of alpha1-antitrypsin in the general population","volume":"67","author":"Ferrarotti","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jhep.2024.04.006_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MPG.0b013e31817b6dfb","article-title":"Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children","volume":"47","author":"Lykavieris","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2024.04.006_bib17","doi-asserted-by":"crossref","first-page":"G156","DOI":"10.1152\/ajpgi.00143.2015","article-title":"Autophagy induced by exogenous bile acids is therapeutic in a model of alpha-1-AT deficiency liver disease","volume":"311","author":"Tang","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2024.04.006_bib18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2205416","article-title":"Fazirsiran for liver disease associated with alpha(1)-antitrypsin deficiency","volume":"387","author":"Strnad","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2024.04.006_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/apt.14537","article-title":"Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease","volume":"47","author":"Townsend","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2024.04.006_bib20","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1016\/j.transproceed.2016.08.047","article-title":"Liver transplantation in polish children with alpha(1)-antitrypsin deficiency: a single-center experience","volume":"48","author":"Bakula","year":"2016","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhep.2024.04.006_bib21","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/hep4.1574","article-title":"Nonfasted liver stiffness correlates with liver disease parameters and portal hypertension in pediatric cholestatic liver disease","volume":"4","author":"Shneider","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2024.04.006_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00535-019-01548-y","article-title":"Liver disease in adults with severe alpha-1-antitrypsin deficiency","volume":"54","author":"Tanash","year":"2019","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jhep.2024.04.006_bib23","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.cgh.2012.07.007","article-title":"Liver test results do not identify liver disease in adults with alpha(1)-antitrypsin deficiency","volume":"10","author":"Clark","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib24","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2019.08.011","article-title":"Assessment of liver phenotype in adults with severe alpha-1 antitrypsin deficiency (Pi\u2217ZZ genotype)","volume":"71","author":"Kumpers","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2019.05.013","article-title":"Liver fibrosis and metabolic alterations in adults with alpha-1-antitrypsin deficiency caused by the Pi\u2217ZZ mutation","volume":"157","author":"Hamesch","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.04.006_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(85)91916-6","article-title":"Smoking, lung function, and alpha 1-antitrypsin deficiency","volume":"1","author":"Janus","year":"1985","journal-title":"Lancet."},{"key":"10.1016\/j.jhep.2024.04.006_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1183\/09031936.99.13224799","article-title":"Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ)","volume":"13","author":"Piitulainen","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhep.2024.04.006_bib28","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1034\/j.1399-3003.2000.15e12.x","article-title":"Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency","volume":"15","author":"Hill","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhep.2024.04.006_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1207\/s15324796abm3301_3","article-title":"Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency","volume":"33","author":"Carpenter","year":"2007","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.jhep.2024.04.006_bib30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1542-3565(05)00082-0","article-title":"Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency","volume":"3","author":"Bowlus","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib31","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/j.gastro.2020.04.058","article-title":"Liver phenotypes of European adults heterozygous or homozygous for Pi \u2217Z variant of AAT (Pi \u2217MZ vs Pi \u2217ZZ genotype) and noncarriers","volume":"159","author":"Schneider","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.04.006_bib32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jhep.2018.08.005","article-title":"Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort","volume":"69","author":"Clark","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gutjnl-2020-323729","article-title":"Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency","volume":"71","author":"Fromme","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.04.006_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cld.2016.12.008","article-title":"Liver transplantation in alpha-1 antitrypsin deficiency","volume":"21","author":"Clark","year":"2017","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib35","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/TP.0000000000002493","article-title":"Outcomes of living-donor liver transplantation using grafts heterozygous for alpha-1 antitrypsin gene mutations","volume":"103","author":"Doshi","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2024.04.006_bib36","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/MEG.0b013e32836171c4","article-title":"Heterozygous alpha1-antitrypsin Z allele mutation in presumed healthy donor livers used for transplantation","volume":"25","author":"Roelandt","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib37","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/lt.20801","article-title":"Peritonitis after liver transplantation: incidence, risk factors, microbiology profiles, and outcome","volume":"12","author":"Pungpapong","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2024.04.006_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.transproceed.2010.11.012","article-title":"Orthotopic liver transplantation in biliary atresia: a single-center experience","volume":"43","author":"Tannuri","year":"2011","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhep.2024.04.006_bib39","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0016-5085(97)70152-5","article-title":"Rapid development of hepatic alpha1-antitrypsin globules after liver transplantation for chronic hepatitis C","volume":"112","author":"Combs","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.04.006_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13075","article-title":"Massive ascites and the heterozygous alpha 1 antitrypsin (alpha(1) AT) living related donor liver in the homozygous child","volume":"22","author":"Khorsandi","year":"2018","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2024.04.006_bib41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.32761","article-title":"Natural history of liver disease in a large international cohort of children with Alagille syndrome: results from the GALA study","volume":"77","author":"Vandriel","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cld.2022.03.002","article-title":"Alagille syndrome: current understanding of pathogenesis, and challenges in diagnosis and management","volume":"26","author":"Ayoub","year":"2022","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib43","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/liv.12920","article-title":"Early life predictive markers of liver disease outcome in an International, Multicentre Cohort of children with Alagille syndrome","volume":"36","author":"Mouzaki","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2024.04.006_bib44","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/hep4.1569","article-title":"Biopsy validated study of biomarkers for liver fibrosis and transplant prediction in inherited cholestasis","volume":"4","author":"Shiau","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2024.04.006_bib45","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep4.1244","article-title":"Placebo-controlled randomized trial of an intestinal bile salt transport inhibitor for pruritus in Alagille syndrome","volume":"2","author":"Shneider","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2024.04.006_bib48","article-title":"Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA","author":"Hansen","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0021-9150(94)05521-J","article-title":"Lipoprotein pattern and plasma lecithin cholesterol acyl transferase activity in children with Alagille syndrome","volume":"115","author":"Gottrand","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jhep.2024.04.006_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jpeds.2004.10.047","article-title":"Evaluation of risk for atherosclerosis in Alagille syndrome and progressive familial intrahepatic cholestasis: two congenital cholestatic diseases with different lipoprotein metabolisms","volume":"146","author":"Nagasaka","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2024.04.006_bib51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cld.2018.06.003","article-title":"Progressive familial intrahepatic cholestasis","volume":"22","author":"Bull","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib53","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000371665","article-title":"ATP8B1 and ATP11C: two lipid flippases important for hepatocyte function","volume":"33","author":"Naik","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib54","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/j.gastro.2005.08.052","article-title":"Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases","volume":"130","author":"Oude","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.04.006_bib55","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/hep.23158","article-title":"Differential effects of progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1 mutations on canalicular localization of ATP8B1","volume":"50","author":"Folmer","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib56","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gut.2004.058115","article-title":"ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy","volume":"54","author":"Mullenbach","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.04.006_bib57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.ejhg.5201355","article-title":"Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy","volume":"13","author":"Painter","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jhep.2024.04.006_bib58","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.31787","article-title":"Impact of genotype, serum bile acids, and surgical biliary diversion on native liver survival in FIC1 deficiency","volume":"74","author":"van Wessel","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib60","article-title":"P1 Analysis of long-term treatment effects of odevixibat on clinical outcomes in children with progressive familial intrahepatic cholestasis in odevixibat clinical studies vs external controls from the NAPPED database","volume":"72","author":"Hansen","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.04.006_bib61","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.932374","article-title":"A report of 2 infant siblings with progressive intrahepatic familial cholestasis type 1 and a novel homozygous mutation in the ATP8B1 gene treated with partial external biliary diversion and liver transplant","volume":"22","author":"Jankowska","year":"2021","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.jhep.2024.04.006_bib62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jceh.2021.03.008","article-title":"Total internal biliary diversion for post-liver transplant PFIC-1-Related allograft injury","volume":"12","author":"Shanmugam","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib63","article-title":"Internal ileal diversion as treatment for progressive familial intrahepatic cholestasis type 1-associated graft inflammation and steatosis after liver transplantation","volume":"9","author":"Kavallar","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/j.jhep.2024.04.006_bib64","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1111\/j.1399-3046.2011.01514.x","article-title":"Recovery of graft steatosis and protein-losing enteropathy after biliary diversion in a PFIC 1 liver transplanted child","volume":"16","author":"Nicastro","year":"2012","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhep.2024.04.006_bib65","article-title":"P8 Odevixibat therapy in patients with FIC1-deficient progressive familial intrahepatic cholestasis and severe diarrhoea following liver transplantation: a retrospective case series","volume":"72","author":"Vogel","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.04.006_bib66","article-title":"Ileal bile acid transporter inhibition reduces post-transplant diarrhea and growth failure in FIC1 disease-A case report","volume":"9","author":"Ohlendorf","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/j.jhep.2024.04.006_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0030-1253224","article-title":"Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy","volume":"30","author":"Pauli-Magnus","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib68","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/apt.16118","article-title":"Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1","volume":"52","author":"Nayagam","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2024.04.006_bib69","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/gut.2008.159541","article-title":"Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy","volume":"58","author":"Dixon","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.04.006_bib70","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/hep.27171","article-title":"Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy","volume":"60","author":"Song","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib71","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.dld.2012.08.011","article-title":"ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population","volume":"45","author":"Anzivino","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib72","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","article-title":"Genotype correlates with the natural history of severe bile salt export pump deficiency","volume":"73","author":"van Wessel","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib73","article-title":"Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency","volume":"5","author":"Felzen","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2024.04.006_bib74","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep4.1168","article-title":"Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies","volume":"2","author":"Bull","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2024.04.006_bib75","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.3748\/wjg.v23.i29.5295","article-title":"Partial external biliary diversion in bile salt export pump deficiency: association between outcome and mutation","volume":"23","author":"Ellinger","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2024.04.006_bib76","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jhep.2017.07.004","article-title":"Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants","volume":"67","author":"Droge","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib77","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhep.2010.01.034","article-title":"Differences in presentation and progression between severe FIC1 and BSEP deficiencies","volume":"53","author":"Pawlikowska","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib78","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/hep.23539","article-title":"ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history","volume":"51","author":"Davit-Spraul","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib79","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/j.gastro.2008.01.038","article-title":"Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families","volume":"134","author":"Strautnieks","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.04.006_bib80","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep.21287","article-title":"Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency","volume":"44","author":"Knisely","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib81","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/hep.20627","article-title":"Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP\/ABCB11","volume":"41","author":"Hayashi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib82","first-page":"682","article-title":"[Physiopathology and management of cholestatic pruritus in children]","volume":"24","author":"Thebaut","year":"2017","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.jhep.2024.04.006_bib83","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3468(98)90435-3","article-title":"Ileal exclusion for Byler's disease: an alternative surgical approach with promising early results for pruritus","volume":"33","author":"Hollands","year":"1998","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jhep.2024.04.006_bib84","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MPG.0b013e31819a4e3d","article-title":"Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease","volume":"49","author":"Yang","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2024.04.006_bib85","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jpedsurg.2016.11.021","article-title":"Outcomes following partial external biliary diversion in patients with progressive familial intrahepatic cholestasis","volume":"52","author":"Lemoine","year":"2017","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jhep.2024.04.006_bib86","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-0040-1714657","article-title":"Partial biliary diversion may promote long-term relief of pruritus and native liver survival in children with cholestatic liver diseases","volume":"31","author":"Bjornland","year":"2021","journal-title":"Eur J Pediatr Surg"},{"key":"10.1016\/j.jhep.2024.04.006_bib87","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpeds.2011.03.004","article-title":"Hepatocellular carcinoma in biliary atresia: king's College Hospital experience","volume":"159","author":"Hadzic","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2024.04.006_bib88","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.23083","article-title":"De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib89","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jhep.2010.05.025","article-title":"Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2","volume":"53","author":"Maggiore","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5223\/pghn.2020.23.2.174","article-title":"Successful treatment with rituximab and immunoadsorption for an auto-antibody induced bile salt export pump deficiency in a liver transplanted patient","volume":"23","author":"Quintero","year":"2020","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"10.1016\/j.jhep.2024.04.006_bib91","article-title":"Cell-based BSEP trans-inhibition: a novel, non-invasive test for diagnosis of antibody-induced BSEP deficiency","volume":"5","author":"Stindt EL","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2024.04.006_bib92","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/gutjnl-2014-306896","article-title":"Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity","volume":"64","author":"Gordo-Gilart","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.04.006_bib94","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpeds.2021.04.040","article-title":"ATP8B1, ABCB11, and ABCB4 genes defects: novel mutations associated with cholestasis with different phenotypes and outcomes","volume":"236","author":"Al-Hussaini","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2024.04.006_bib95","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/hep4.1149","article-title":"Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset","volume":"2","author":"Schatz","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2024.04.006_bib96","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s13023-022-02597-y","article-title":"Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures","volume":"17","author":"Chen","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib97","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ng.3247","article-title":"Large-scale whole-genome sequencing of the Icelandic population","volume":"47","author":"Gudbjartsson","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2024.04.006_bib98","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-2-29","article-title":"Low phospholipid associated cholelithiasis: association with mutation in the MDR3\/ABCB4 gene","volume":"2","author":"Rosmorduc","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib99","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1111\/liv.14662","article-title":"Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma","volume":"40","author":"de Vries","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2024.04.006_bib100","article-title":"Low-phospholipid-associated cholelithiasis syndrome: prevalence, clinical features, and comorbidities","volume":"3","author":"Dong","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2024.04.006_bib101","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2012.01.025","article-title":"ABCB4\/MDR3 gene mutations and cholangiocarcinomas","volume":"57","author":"Tougeron","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib102","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.dld.2020.12.003","article-title":"ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed","volume":"53","author":"Avena","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib103","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0031-1273427","article-title":"Cholestatic liver diseases from child to adult: the diversity of MDR3 disease","volume":"49","author":"Kubitz","year":"2011","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.jhep.2024.04.006_bib104","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.dld.2021.07.003","article-title":"The wide phenotypic and genetic spectrum of ABCB4 gene deficiency: a case series","volume":"54","author":"Falcao","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.gastro.2008.03.044","article-title":"ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults","volume":"135","author":"Ziol","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.04.006_bib106","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"Electronic address eee, Clinical Practice Guideline P, Chair, representative EGB, Panel m. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib107","article-title":"A BCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome","volume":"4","author":"Biyoukar","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2024.04.006_bib108","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jhep.2015.03.010","article-title":"Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort study","volume":"63","author":"Wikstrom","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib109","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/hep.26444","article-title":"Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study","volume":"58","author":"Marschall","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib110","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/1471-0528.12174","article-title":"Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study","volume":"120","author":"Wikstrom Shemer","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.jhep.2024.04.006_bib111","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejogrb.2019.06.008","article-title":"Long-term survival after intrahepatic cholestasis of pregnancy: a follow-up of 571 mothers","volume":"240","author":"Hamalainen","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jhep.2024.04.006_bib115","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.04.006_bib116","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.26424","article-title":"Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patients","volume":"58","author":"Poupon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib117","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/gast.2001.23947","article-title":"MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis","volume":"120","author":"Rosmorduc","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.04.006_bib119","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/gutjnl-2019-319057","article-title":"Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis","volume":"69","author":"Harms","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.04.006_bib121","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib122","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jhep.2023.05.049","article-title":"Where does genetic testing fit in the diagnostic pathway of patients with cryptogenic cirrhosis?","volume":"79","author":"Nayagam","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib123","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2019.01.036","article-title":"Clinical utility of genomic analysis in adults with idiopathic liver disease","volume":"70","author":"Hakim","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib124","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1172\/JCI112915","article-title":"Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids","volume":"79","author":"Clayton","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2024.04.006_bib125","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1172\/JCI113837","article-title":"Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis","volume":"82","author":"Setchell","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2024.04.006_bib126","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI10902","article-title":"The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis","volume":"106","author":"Schwarz","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2024.04.006_bib127","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1210\/jc.2002-021580","article-title":"Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease","volume":"88","author":"Cheng","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhep.2024.04.006_bib128","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.52.10.1494","article-title":"Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy","volume":"52","author":"Lemonde","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.04.006_bib129","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jhep.2003.12.024","article-title":"SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase deficiency: evidence for primary genetic defect","volume":"40","author":"Gonzales","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib130","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/MPG.0000000000001546","article-title":"Attempt to determine the prevalence of two inborn errors of primary bile acid synthesis: results of a European survey","volume":"64","author":"Jahnel","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2024.04.006_bib131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jhep.2024.04.006_bib132","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10545-010-9259-3","article-title":"Disorders of bile acid synthesis","volume":"34","author":"Clayton","year":"2011","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2024.04.006_bib133","first-page":"S17","article-title":"Defects in bile acid biosynthesis--diagnosis and treatment","volume":"43","author":"Setchell","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2024.04.006_bib134","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1432-1033.1997.00039.x","article-title":"Differential interaction of bile acids from patients with inborn errors of bile acid synthesis with hepatocellular bile acid transporters","volume":"244","author":"Stieger","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jhep.2024.04.006_bib135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0022-3476(05)83280-9","article-title":"A new cause of progressive intrahepatic cholestasis: 3 beta-hydroxy-C27-steroid dehydrogenase\/isomerase deficiency","volume":"125","author":"Jacquemin","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2024.04.006_bib136","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/hep.1840180513","article-title":"Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (delta 4-3-oxosteroid 5 beta-reductase deficiency)","volume":"18","author":"Daugherty","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib139","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e3181b47b34","article-title":"Variable clinical spectrum of the most common inborn error of bile acid metabolism--3beta-hydroxy-Delta 5-C27-steroid dehydrogenase deficiency","volume":"50","author":"Subramaniam","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2024.04.006_bib140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1750-1172-8-74","article-title":"A combination of mutations in AKR1D1 and SKIV2L in a family with severe infantile liver disease","volume":"8","author":"Morgan","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib141","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/MPG.0000000000001734","article-title":"Bile acid synthesis disorders in arabs: a 10-year screening study","volume":"65","author":"Al-Hussaini","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2024.04.006_bib143","series-title":"Drug Trials Snapshot: CHOLBAM (bile acid synthesis disorders)","year":"2015"},{"key":"10.1016\/j.jhep.2024.04.006_bib144","series-title":"Orphacol","author":"Agency","year":"2013"},{"key":"10.1016\/j.jhep.2024.04.006_bib145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13023-018-0920-5","article-title":"Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood","volume":"13","author":"Gonzales","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2024.04.006_bib146","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2796.2007.01814.x","article-title":"Cholestatic liver disease in adults may be due to an inherited defect in bile acid biosynthesis","volume":"262","author":"Fischler","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.jhep.2024.04.006_bib147","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.24781","article-title":"Homozygosity mapping identifies a bile acid biosynthetic defect in an adult with cirrhosis of unknown etiology","volume":"55","author":"Molho-Pessach","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.04.006_bib148","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2016.11.013","article-title":"The management of childhood liver diseases in adulthood","volume":"66","author":"Joshi","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.04.006_bib149","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s13023-023-02984-z","article-title":"\u0394(4)-3-oxo-5beta-reductase deficiency: favorable outcome in 16 patients treated with cholic acid","volume":"18","author":"Gardin","year":"2023","journal-title":"Orphanet J Rare Dis"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824002745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824002745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:58:20Z","timestamp":1773457100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827824002745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":157,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0168827824002745"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.04.006","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EASL Clinical Practice Guidelines on genetic cholestatic liver diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}